414 related articles for article (PubMed ID: 23937413)
21. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
22. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice.
Lee KS; Kim SR; Park HS; Park SJ; Min KH; Lee KY; Jin SM; Lee YC
J Allergy Clin Immunol; 2007 Jan; 119(1):141-9. PubMed ID: 17208595
[TBL] [Abstract][Full Text] [Related]
23. Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.
Hamamoto Y; Ano S; Allard B; O'Sullivan M; McGovern TK; Martin JG
Br J Pharmacol; 2017 Oct; 174(19):3346-3358. PubMed ID: 28718891
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma.
Trinh HKT; Suh DH; Nguyen TVT; Choi Y; Park HS; Shin YS
Prostaglandins Leukot Essent Fatty Acids; 2019 Feb; 141():17-23. PubMed ID: 30661601
[TBL] [Abstract][Full Text] [Related]
25. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
[TBL] [Abstract][Full Text] [Related]
26. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
27. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
Bai JW; Deng WW; Wu HC
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000
[TBL] [Abstract][Full Text] [Related]
28. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of CysLT
Matsuda M; Tabuchi Y; Nishimura K; Nakamura Y; Sekioka T; Kadode M; Kawabata K; Nabe T
Prostaglandins Leukot Essent Fatty Acids; 2018 Apr; 131():24-31. PubMed ID: 29628047
[TBL] [Abstract][Full Text] [Related]
30. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Han J; Jia Y; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2010 Aug; 182(4):455-63. PubMed ID: 20442434
[TBL] [Abstract][Full Text] [Related]
31. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
32. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice.
Mao H; Yin KS; Wang ZL; Li FY; Zhang XL; Liu CT; Lei S
Chin Med J (Engl); 2004 Apr; 117(4):592-7. PubMed ID: 15109455
[TBL] [Abstract][Full Text] [Related]
33. Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
Patel B; Gupta N; Ahsan F
Pharm Res; 2014 Nov; 31(11):3095-105. PubMed ID: 24934662
[TBL] [Abstract][Full Text] [Related]
34. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
35. Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling.
Ueno H; Koya T; Takeuchi H; Tsukioka K; Saito A; Kimura Y; Hayashi M; Watanabe S; Hasegawa T; Arakawa M; Kikuchi T
Am J Respir Cell Mol Biol; 2020 Jul; 63(1):57-66. PubMed ID: 32182104
[TBL] [Abstract][Full Text] [Related]
36. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
Hosoki K; Kainuma K; Toda M; Harada E; Chelakkot-Govindalayathila AL; Roeen Z; Nagao M; D'Alessandro-Gabazza CN; Fujisawa T; Gabazza EC
Biochem Biophys Res Commun; 2014 Jul; 449(3):351-6. PubMed ID: 24845378
[TBL] [Abstract][Full Text] [Related]
37. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
38. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
39. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
[TBL] [Abstract][Full Text] [Related]
40. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats.
Ihaku D; Cameron L; Suzuki M; Molet S; Martin J; Hamid Q
J Allergy Clin Immunol; 1999 Dec; 104(6):1147-54. PubMed ID: 10588994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
